Sastasundar Ventures Ltd Stock Price Today (NSE: SASTASUNDR)
Fundamental Score
Sastasundar Ventures Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Sastasundar Ventures Ltd share price today is ₹307.25, down 1.40% on NSE/BSE as of 1 June 2026. Sastasundar Ventures Ltd (SASTASUNDR) is a Small-cap company in the Healthcare Service Provider sector with a market capitalisation of ₹1.04K (Cr). The 52-week high for SASTASUNDR share price is ₹363.00 and the 52-week low is ₹252.50. The company has a Return on Equity (ROE) of 4.63% and a debt-to-equity ratio of 0.01.
Sastasundar Ventures Ltd Share Price Chart — NSE/BSE Historical Performance
Sastasundar Ventures Ltd share price chart: 15.93% return over the past month. 52-week high ₹363.00, 52-week low ₹252.50.
Sastasundar Ventures Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹322.45 | ₹322.45 | ₹310.00 | ₹313.95 | 13.40K (Cr) | |
| ₹297.50 | ₹334.40 | ₹287.80 | ₹322.45 | 58.71K (Cr) | |
| ₹290.00 | ₹290.00 | ₹285.70 | ₹289.05 | 1.05K (Cr) | |
| ₹298.00 | ₹298.00 | ₹280.50 | ₹284.75 | 7.43K (Cr) | |
| ₹285.00 | ₹289.50 | ₹283.45 | ₹288.15 | 1.23K (Cr) | |
| ₹290.00 | ₹298.50 | ₹281.00 | ₹285.50 | 10.55K (Cr) | |
| ₹277.60 | ₹296.80 | ₹276.55 | ₹292.50 | 10.10K (Cr) | |
| ₹288.75 | ₹289.50 | ₹281.50 | ₹284.05 | 2.61K (Cr) | |
| ₹281.50 | ₹294.10 | ₹277.50 | ₹287.15 | 5.15K (Cr) | |
| ₹283.10 | ₹285.90 | ₹274.60 | ₹278.10 | 5.01K (Cr) |
Sastasundar Ventures Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹277.00 | ₹334.40 | ₹269.00 | ₹313.95 | +13.34% | |
| ₹265.05 | ₹298.40 | ₹264.00 | ₹281.75 | +6.30% | |
| ₹284.05 | ₹296.80 | ₹252.50 | ₹256.95 | -9.54% | |
| ₹292.80 | ₹311.45 | ₹276.00 | ₹283.25 | -3.26% | |
| ₹298.25 | ₹363.00 | ₹289.95 | ₹296.90 | -0.45% | |
| ₹328.35 | ₹330.00 | ₹293.30 | ₹295.10 | -10.13% | |
| ₹294.00 | ₹334.40 | ₹275.00 | ₹328.35 | +11.68% | |
| ₹305.95 | ₹328.00 | ₹292.35 | ₹295.50 | -3.42% | |
| ₹273.75 | ₹338.00 | ₹267.00 | ₹305.05 | +11.43% | |
| ₹285.50 | ₹295.70 | ₹266.35 | ₹272.55 | -4.54% | |
| ₹297.00 | ₹317.00 | ₹266.20 | ₹285.20 | -3.97% | |
| ₹262.50 | ₹342.00 | ₹257.05 | ₹296.90 | +13.10% |
AI Research Briefing
Powered by Gemini · 2026-04-09
Micro-cap turnaround story with too many red flags; avoid until profitability is proven.
WHAT'S HAPPENING NOW (last 2-4 weeks)
Sastasundar Ventures changed its name to Health X Platform Limited. Recent news includes disclosures related to insider trading regulations, including promoter stake increases. The trading window closed on April 1st, 2026, and will reopen 48 hours after the declaration of audited financial results for the quarter and financial year ended March 31st, 2026.
CORE STORY (THE REAL GAME)
Sastasundar is attempting a turnaround by focusing on its digital healthcare platform and curated generics, aiming to become a significant player in the affordable medicine market. The name change to Health X Platform signals a broader strategic shift.
- Name change to Health X Platform
- Focus on digital healthcare platform
- Investment in AI and technology
- Successful implementation of digital healthcare strategy
- Profitability in FY26
- Significant increase in B2C business
- Negative Interest Coverage Ratio
- Negative Free Cash Flow
- Micro-cap liquidity risk
FII increased stake by 0.16%, DII decreased stake by 0.02%. Promoter holding steady at 74.24%.
Indian healthcare is moving towards digital systems and AI integration, but quality and data protection are key concerns.
No, Free Cash Flow 5Y is ₹-376.58 Cr.
Focus on digital healthcare and affordable generics could drive growth, but profitability is key. Monitor execution of turnaround plan and financial performance closely.
Primary Thesis Risk
Inability to achieve profitability and manage debt could lead to collapse.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Sastasundar Ventures Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Sastasundar Ventures Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of SASTASUNDR across key market metrics for learning purposes.
Positive Indicators
7 factors identified
Strong Operating Margins (15.89%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Consistent Growth Track Record (24.47% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (23.31% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (23.31% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.01)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Balanced Promoter Holding (74.24%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
7 factors identified
Below-Average Return on Equity (4.63%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (-1.33%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Profit Decline Concern (-151.27%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Weak Interest Coverage (-158.05x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Negative Free Cash Flow (₹-376.58 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 4.11%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Sastasundar Ventures Ltd vs Healthcare Service Provider Peers
Peer Comparison - Healthcare Service Provider
Compare Sastasundar Ventures Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Sastasundar Ventures LtdSastasundar Ven...Selected✓ SASTASUNDR • 533259 | 40.3/100 | ₹307.25₹307 | ₹1042.27₹1042.27 | — — | 4.63%Poor 4.63% Poor | -1.33%Poor -1.33% Poor | 0.01Excellent 0.0 Excellent | 23.31%Excellent 23.31% Excellent | 24.47%Excellent 24.47% Excellent | 0.00% |
Dr Lal PathLabs LtdDr Lal PathLabs... LALPATHLAB • 539524 | 64.3/100 | ₹1617.20₹1617 | ₹25557.40₹25557.40 | 47.83Average 47.8 Average | 24.30%Excellent 24.30% Excellent | 28.88%Excellent 28.88% Excellent | 0.07Excellent 0.1 Excellent | 16.69%Excellent 16.69% Excellent | 13.09%Good 13.09% Good | 0.79% |
Vijaya Diagnostic Centre LtdVijaya Diagnost... VIJAYA • 543350 | 53.7/100 | ₹1261.40₹1261 | ₹10272.45₹10272.45 | 67.39Average 67.4 Average | 19.00%Good 19.00% Good | 20.91%Excellent 20.91% Excellent | 0.42Excellent 0.4 Excellent | 18.97%Excellent 18.97% Excellent | 15.00%Excellent 15.00% Excellent | 0.20% |
Metropolis Healthcare LtdMetropolis Heal... METROPOLIS • 542650 | 48.9/100 | ₹536.15₹536 | ₹10124.28₹10124.28 | 63.98Average 64.0 Average | 11.53%Average 11.53% Average | 14.66%Average 14.66% Average | 0.14Excellent 0.1 Excellent | -0.56%Poor -0.56% Poor | 9.22%Good 9.22% Good | 0.20% |
Thyrocare Technologies LtdThyrocare Techn... THYROCARE • 539871 | 40.5/100 | ₹512.15₹512 | ₹7724.80₹7724.80 | 60.48Average 60.5 Average | 16.15%Good 16.15% Good | 24.78%Excellent 24.78% Excellent | 0.05Excellent 0.1 Excellent | -0.64%Poor -0.64% Poor | 9.62%Good 9.62% Good | 1.44% |
Krsnaa Diagnostics LtdKrsnaa Diagnost... KRSNAA • 543328 | 39.6/100 | ₹538.45₹538 | ₹2626.09₹2626.09 | 30.73Average 30.7 Average | 9.29%Poor 9.29% Poor | 12.52%Average 12.52% Average | 0.30Excellent 0.3 Excellent | 22.05%Excellent 22.05% Excellent | 21.41%Excellent 21.41% Excellent | 0.34% |
Suraksha Diagnostic LtdSuraksha Diagno... SURAKSHA • 544293 | 47.1/100 | ₹289.60₹290 | ₹1534.08₹1534.08 | 48.05Average 48.0 Average | 16.46%Good 16.46% Good | 17.84%Good 17.84% Good | 0.51Good 0.5 Good | 16.38%Excellent 16.38% Excellent | 9.86%Good 9.86% Good | 0.00% |
3B Blackbio Diagnostics Ltd3B Blackbio Dia... 3BBLACKBIO • 532067 | 66.1/100 | ₹1225.40₹1225 | ₹1080.56₹1080.56 | 22.01Average 22.0 Average | 19.40%Good 19.40% Good | 25.75%Excellent 25.75% Excellent | 0.00Excellent 0.0 Excellent | 44.03%Excellent 44.03% Excellent | 27.29%Excellent 27.29% Excellent | 0.32% |
One Global Service Provider IncOne Global Serv... ONEGLOBAL • 514330 | 69.5/100 | ₹424.15₹424 | ₹1070.08₹1070.08 | 24.39Average 24.4 Average | 42.31%Excellent 42.31% Excellent | 56.38%Excellent 56.38% Excellent | 0.00Excellent 0.0 Excellent | 128.82%Excellent 128.82% Excellent | — — | 0.00% |
46.5/100 | ₹233.90₹234 | ₹826.72₹826.72 | 30.47Average 30.5 Average | 27.08%Excellent 27.08% Excellent | 28.85%Excellent 28.85% Excellent | 0.48Excellent 0.5 Excellent | — — | — — | 0.00% | |
Choksi Imaging LtdChoksi Imaging ... CHOKSI • 526546 | 45.3/100 | ₹126.35₹126 | ₹92.81₹92.81 | 55.91Average 55.9 Average | 6.63%Poor 6.63% Poor | 9.20%Poor 9.20% Poor | 1.18Average 1.2 Average | 32.13%Excellent 32.13% Excellent | 8.21%Good 8.21% Good | 0.00% |
Top Healthcare Service Provider Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Dr Lal PathLabs Ltd share price25557.40 Cr
- Vijaya Diagnostic Centre Ltd share price10272.45 Cr
- Metropolis Healthcare Ltd share price10124.28 Cr
- Thyrocare Technologies Ltd share price7724.80 Cr
- Krsnaa Diagnostics Ltd share price2626.09 Cr
Sastasundar Ventures Ltd PE Ratio History
Historical price-to-earnings ratio for SASTASUNDR — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2024 | ₹2.79 | ₹316.85 | 113.6x |
| FY 2022 | ₹197.04 | ₹281.10 | 1.4x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Sastasundar Ventures Ltd Quarterly Performance
Latest quarterly metrics for SASTASUNDR — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
10.16%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-151.27%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
24.47%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
23.31%
Compounded annual net profit growth over 5 years
Sastasundar Ventures Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for SASTASUNDR — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Sastasundar Ventures Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Sastasundar Ventures Ltd (SASTASUNDR) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Sastasundar Ventures Ltd
About SASTASUNDR (Sastasundar Ventures Ltd)
Sastasundar Ventures Ltd is a dynamic healthcare service provider revolutionizing access to health and wellness solutions across India. They are building a comprehensive ecosystem ...that seamlessly integrates digital platforms with physical touchpoints, striving to bridge the gap between quality healthcare and affordability. Focusing on leveraging technology, Sastasundar is constructing a vast network that encompasses online pharmacies, diagnostic services, and wellness product marketplaces. They are deeply invested in creating a user-centric experience, prioritizing convenience and transparency in all their operations. By building robust supply chains and streamlining processes, Sastasundar aims to deliver accessible and reliable healthcare services to a diverse population. At the heart of Sastasundar's operations lies a commitment to utilizing technology for improved health outcomes. Through their innovative digital platform, individuals can easily access a wide array of healthcare products and services from the comfort of their homes. This digital reach extends to online consultations, medicine delivery, and diagnostic test bookings, catering to the growing demand for remote healthcare solutions. Sastasundar is dedicated to fostering a proactive approach to wellness by offering personalized health information and curated product recommendations. This holistic focus on patient engagement empowers individuals to take control of their well-being and make informed healthcare decisions. Sastasundar's business model extends beyond merely providing access; they are actively investing in building a strong and reliable healthcare infrastructure. This includes partnering with local pharmacies, diagnostic labs, and healthcare professionals to create a unified network that ensures quality and consistency in service delivery. Through strategic collaborations, Sastasundar is working to enhance healthcare accessibility, particularly in underserved areas. They are focused on building a future where every individual, regardless of their location or socioeconomic status, has access to the healthcare resources they need to live a healthier life.
Company Details
Key Leadership
Corporate Events
SASTASUNDR Share Price: Frequently Asked Questions
What is the current share price of Sastasundar Ventures Ltd?
Sastasundar Ventures Ltd (SASTASUNDR) trades at ₹307.25 on NSE and BSE. Market cap ₹1.04K (Cr). Educational data only.
What is the P/E ratio of Sastasundar Ventures Ltd?
Sastasundar Ventures Ltd has a P/E of N/Ax vs industry average 39.28x.
What is the Bull Run score for Sastasundar Ventures Ltd?
Sastasundar Ventures Ltd has a Bull Run score of 40.3/100 based on 25+ financial parameters.
Does Sastasundar Ventures Ltd pay dividends?
Sastasundar Ventures Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Sastasundar Ventures Ltd?
Sastasundar Ventures Ltd has ROE of 4.63%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Sastasundar Ventures Ltd?
Sastasundar Ventures Ltd has debt-to-equity of 0.01.
Is Sastasundar Ventures Ltd a good investment?
Bull Run gives Sastasundar Ventures Ltd a score of 40.3/100. This is not investment advice — consult a SEBI-registered advisor.